Cartesian Therapeutics Inc (RNAC)

Income Before Tax

$15.77M

Quarterly · Period ending: · USD

RNAC logo

RNAC Income Before Tax

Latest reported$15.77M
RNAC Quarterly Pre-Tax Income (-$5.73M → $15.77M)
High-resolution chart · PNG

RNAC income before tax history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Income Before Tax — Quarterly (USD)
Period endingIncome Before Tax (USD)
15,769,000
-39,182,000
-101,769,000
-35,902,000
15,886,000
-17,710,000
-9,966,000
-24,183,000
13,836,000
-56,824,000
-196,658,000
-9,002,000
-11,387,000
-21,663,000
5,605,000
-8,214,000
8,601,000
28,778,000
12,377,000
-2,066,000
4,565,000
-24,597,000
-15,446,000
-9,729,000
-24,081,000
-19,620,000
-14,888,000
-11,994,000
-16,394,000
-12,074,000
-14,651,000
-16,001,000
-18,796,000
-15,888,000
-19,544,000
-14,676,000
-15,967,000
-15,134,000
-14,083,000
-7,728,000
-6,923,000
-7,476,000
-6,849,000
-5,725,000
-6,867,000
-5,733,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.